iopamidol has been researched along with Experimental Mammary Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aime, S; Bardini, P; Consolino, L; Digilio, G; Longo, DL; Michelotti, F; Sun, PZ; Xiao, G | 1 |
Anemone, A; Consolino, L; Longo, DL | 1 |
Burgener, FA; Steinmetz, SD | 1 |
3 other study(ies) available for iopamidol and Experimental Mammary Neoplasms
Article | Year |
---|---|
In Vitro and In Vivo Assessment of Nonionic Iodinated Radiographic Molecules as Chemical Exchange Saturation Transfer Magnetic Resonance Imaging Tumor Perfusion Agents.
Topics: Animals; Contrast Media; Hydrogen-Ion Concentration; In Vitro Techniques; Iohexol; Iopamidol; Magnetic Resonance Imaging; Mammary Neoplasms, Experimental; Mice; Tomography, X-Ray Computed; Triiodobenzoic Acids | 2016 |
MRI-CEST assessment of tumour perfusion using X-ray iodinated agents: comparison with a conventional Gd-based agent.
Topics: Animals; Contrast Media; Female; Gadolinium; Heterocyclic Compounds; Image Enhancement; Iohexol; Iopamidol; Magnetic Resonance Imaging; Male; Mammary Neoplasms, Experimental; Neovascularization, Pathologic; Organometallic Compounds; Perfusion; Radiography; Reproducibility of Results; Triiodobenzoic Acids | 2017 |
Comparison of diatrizoate, iopamidol, and ioxaglate for the contrast enhancement of experimental hepatic tumors in CT.
Topics: Adenocarcinoma; Animals; Cell Line; Colonic Neoplasms; Contrast Media; Diatrizoate; Iodine; Iodobenzoates; Iopamidol; Iothalamic Acid; Ioxaglic Acid; Kinetics; Liver; Liver Neoplasms, Experimental; Mammary Neoplasms, Experimental; Rats; Rats, Inbred Strains; Time Factors; Tomography, X-Ray Computed; Triiodobenzoic Acids | 1985 |